BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 200493)

  • 1. Pancreatic action of the sulfonylureas.
    Grodsky GM; Epstein GH; Fanska R; Karam JH
    Fed Proc; 1977 Dec; 36(13):2714-9. PubMed ID: 200493
    [No Abstract]   [Full Text] [Related]  

  • 2. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V; Cerasi E
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
    Macchi IA; Zeytinoğlu FN
    Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
    Dunbar JC; Walsh MF; Foà PP
    Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
    Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
    Krause U; Puchinger H; Wacker A
    Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of sulfonylurea stimulation of insulin release.
    Hellman B
    Acta Biol Med Ger; 1982; 41(12):1211-9. PubMed ID: 6765162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Pro-) insulin biosynthesis and release of newly synthesized (pro-) insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas.
    Schatz H; Nierle C; Pfeiffer EF
    Eur J Clin Invest; 1975 Nov; 5(6):477-85. PubMed ID: 811472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 14. Early insulin and glucagon response to subsequent pulses of arginine, glucose, and tolbutamide in normal man.
    Greco AV; Manna R; Ghirlanda G; Altomonte L; Rebuzzi AG; Bertoli A
    Am J Physiol; 1979 Feb; 236(2):E85-9. PubMed ID: 369391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of acid amyloglucosidase in sulphonylurea-induced insulin release.
    Lundquist I
    Diabetologia; 1974 Dec; 10(6):717-24. PubMed ID: 4374400
    [No Abstract]   [Full Text] [Related]  

  • 17. The stimulus-secretion coupling of glucose-induced insulin release-XVII. Effects of sulfonylureas and diazoxide on insular biosynthetic activity.
    Levy J; Malaisse WJ
    Biochem Pharmacol; 1975 Jan; 24(2):235-9. PubMed ID: 1089409
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.
    Garcia SD; Jarrousse C; Rosselin G
    J Clin Invest; 1976 Jan; 57(1):230-43. PubMed ID: 173741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and secretion of insulin in dynamic perfusion systems.
    Grodsky GM; Sando H; Levin S; Gerich J; Karam J
    Adv Metab Disord; 1974; 7(0):155-70. PubMed ID: 4607146
    [No Abstract]   [Full Text] [Related]  

  • 20. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
    Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
    Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.